Clinical Characteristics, Surgical Management And Outcomes Of Abdominal Pain Among SARS-COV-2 Infected Patients: A Chart Review

Vasitha Abeysuriya, Chandima De Mel, Lal Chandrasena, Visula Abeysuriya

Abstract


Introduction:

A significant proportion of patients with SARS-CoV-2 present with different gastrointestinal manifestations. Abdominal pain is one such. Surgical referrals are frequently done since it mimics sinister abdominal pathology. However, surgical management and follow up guidelines of abdominal pain are still underdeveloped. Surgical interventions without careful clinical judgment may lead to catastrophic outcomes. Our aim is to determine the characteristics of abdominal pain, management and outcome among selected COVID-19 infected patients.

Martial and Method:

A chart review was conducted among COVID-19 patients with abdominal pain who were referred for surgical opinions in a private hospital from February 2021 to September 2021. Demographic, signs and symptoms, clinical findings, biochemical investigations and outcomes were recorded.  The site of the abnormal pain was classified according to standard nine quadrants surgical demarcation of the abdomen. 

Results: We collected data on 40 (Male n=22, 55%) referred patients (mild: n= 25 [62.5%], moderate: n=15[37.5%] and no severe cases). The median age was 51years.  Patients were referred for surgical opinion median day of 4 from the illness. The commonest quadrant of abdominal pain was the right iliac fossa (n=30 [75%]). On clinical examination, 87.5 %( n=35) abdomen was soft and non-tender. Supportive therapy and close observations were carried out. Symptoms were remised within two to three days.

 

 Conclusion:

Our study shows that the abdominal pain among COVID-19 patient with mild to moderate disease are not associated with sinister abdominal pathologies and can be managed conservatively. Further studies need to develop surgical management guidelines for this category of patients.


Keywords


COVID-19, Abdominal pain, Right iliac fossa

Full Text:

PDF

References


Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery. 2020;76: 71–76. doi:10.1016/j.ijsu.2020.02.034

Rahman A, Niloofa R, Jayarajah U, De Mel S, Abeysuriya V, Seneviratne SL. Hematological abnormalities in COVID-19: A narrative review. American Journal of Tropical Medicine and Hygiene. American Society of Tropical Medicine and Hygiene; 2021. pp. 1188–1201. doi:10.4269/ajtmh.20-1536

Rahman A, Niloofa R, De Zoysa IM, Cooray AD, Kariyawasam J, Seneviratne SL. Neurological manifestations in COVID-19: A narrative review. SAGE Open Medicine. 2020;8: 205031212095792. doi:10.1177/2050312120957925

Vinayagam S, Sattu K. SARS-CoV-2 and coagulation disorders in different organs. Life Sciences. 2020;260: 118431. doi:10.1016/j.lfs.2020.118431

Ashraf S, Felske D, Singh C, Rajaram SS. Gastrointestinal manifestations of COVID-19. COVID-19 by Cases: A Pandemic Review. Nova Science Publishers, Inc.; 2021. pp. 109–117. doi:10.1093/trstmh/trab042

Mandal A, Konala VM, Adapa S, Naramala S, Gayam V. Gastrointestinal Manifestations in COVID-19 Infection and Its Practical Applications. Cureus. 2020. doi:10.7759/cureus.8750

Mokhtari T, Hassani F, Ghaffari N, Ebrahimi B, Yarahmadi A, Hassanzadeh G. COVID-19 and multiorgan failure: A narrative review on potential mechanisms. Journal of Molecular Histology. 2020;51: 613–628. doi:10.1007/s10735-020-09915-3

Mokarram P, Dalivand MM, Pizuorno A, Aligolighasemabadi F, Sadeghdoust M, Sadeghdoust E, et al. Clinical characteristics, gastrointestinal manifestations and outcomes of COVID-19 patients in Iran; does the location matters? World Journal of Clinical Cases. 2021;9: 4654–4667. doi:10.12998/wjcc.v9.i18.4654

Rokkas T. Gastrointestinal involvement in COVID-19: a systematic review and meta-analysis. Annals of Gastroenterology. 2020. doi:10.20524/aog.2020.0506

Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Alimentary Pharmacology & Therapeutics. 2020;51: 843–851. doi:10.1111/apt.15731

Patel KP, Patel PA, Vunnam RR, Hewlett AT, Jain R, Jing R, et al. Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19. Journal of Clinical Virology. 2020;128: 104386. doi:10.1016/j.jcv.2020.104386

Hunt RH, East JE, Lanas A, Malfertheiner P, Satsangi J, Scarpignato C, et al. COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist. Digestive Diseases. S. Karger AG; 2021. pp. 119–139. doi:10.1159/000512152

World Health Organization. Clinical Management of COVID-19: Interim Guidance. World Health Organization. 2020; 13–15.

Mehraeen E, Karimi A, Barzegary A, Vahedi F, Afsahi AM, Dadras O, et al. Predictors of mortality in patients with COVID-19–a systematic review. European Journal of Integrative Medicine. 2020;40: 101226. doi:10.1016/j.eujim.2020.101226

Boonyawat K, Chantrathammachart P, Numthavej P, Nanthatanti N, Phusanti S, Phuphuakrat A, et al. Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis. Thrombosis Journal. 2020;18: 34. doi:10.1186/s12959-020-00248-5

Yu D, Du Q, Yan S, Guo XG, He Y, Zhu G, et al. Liver injury in COVID-19: clinical features and treatment management. Virology Journal. BioMed Central Ltd; 2021. p. 121. doi:10.1186/s12985-021-01593-1

Chadalavada P, Padbidri V, Garg R, Alomari M, Babar A, Kewan T, et al. Transaminases are Potential Biomarkers of Disease Severity in COVID-19 Patients: A Single-Center Experience. Cureus. 2020;12. doi:10.7759/cureus.11555

Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infectious Diseases of Poverty. 2020;9: 45. doi:10.1186/s40249-020-00662-x

Andrews PLR, Cai W, Rudd JA, Sanger GJ. COVID‐19, nausea, and vomiting. Journal of Gastroenterology and Hepatology. 2021;36: 646–656. doi:10.1111/jgh.15261

Singh P, Yoon SS, Kuo B. Nausea: A review of pathophysiology and therapeutics. Therapeutic Advances in Gastroenterology. SAGE Publications; 2016. pp. 98–112. doi:10.1177/1756283X15618131

Hayashi Y, Wagatsuma K, Nojima M, Yamakawa T, Ichimiya T, Yokoyama Y, et al. The characteristics of gastrointestinal symptoms in patients with severe COVID-19: a systematic review and meta-analysis. Journal of Gastroenterology. Springer Japan; 2021. pp. 409–420. doi:10.1007/s00535-021-01778-z

Gibson T. Abdominal Pain. Comprehensive Pediatric Hospital Medicine. Elsevier Inc.; 2007. pp. 120–124. doi:10.1016/B978-032303004-5.50030-2




DOI: http://dx.doi.org/10.52155/ijpsat.v34.2.4449

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Vasitha Abeysuriya, Chandima De Mel, Lal Chandrasena, Visula Abeysuriya

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.